The DOI matches its Crossref record, with a small difference in title or year; 39 of the 39 references it cites were found in a registry or an index.
Cigarette Smoking and Mortality Risk in People With Schizophrenia
Open accessAbstract
This study examined effects of cigarette smoking on mortality risk in 1213 persons aged 19-69 years with schizophrenia-related psychotic disorders admitted to State of Maryland Hospitals between 1994 and 2000. Inpatient medical records from 7 hospitals were reviewed to obtain demographic information, diagnosis, medication use, as well as smoking and other substance use. Social Security Death Index data were used to identify deaths in the study group between 1994 and 2004. Death records were reviewed to obtain manner of death and underlying disorders. Of the 1213, 55% were smokers and 71% abused substances. There was an age × smoking interaction (χ(2) = 14.6, df = 1, P = .0001) for mortality, with estimated hazard ratios (HRs) for smokers vs nonsmokers of 2.1 among 35- to 54-year olds and HR of 0.7 among those aged 55-69 years. Five- and 10-year mortality rates for smokers aged 35-54 years were 7.0% and 14.2%, compared with 3.3% and 10.0% for nonsmokers, respectively (χ(2) = 5.53, df = 1, P = .019). Cardiac causes were identified in 43% of deaths in smokers but only 19% of deaths in nonsmokers (P < .006). For those aged 35-54 years, the odds of cardiac related death was increased by 12 fold in smokers relative to nonsmokers (HR = 12.4, χ(2) = 12.0, df = 1, P = .0005). Among people aged 35-54 years, those smoking greater than one pack daily have a significantly increased total mortality risk (HR = 2.7) vs nonsmokers. Cigarette smoking, particularly in people aged 35-54 years, contributes to an increased risk of death. Greater smoking severity significantly increases this risk. Smoking cessation in people with schizophrenia deserves significant attention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although mortality risk was slightly lower in cases from the BME compared with the white British group, in contrast to earlier research,23,24 we found no difference beyond what would be expected by chance.”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [24]
In the citing paper
“the absence of systematic differences across ethnic groups or, as has been reported earlier, an even lower mortality risk in BME groups,23,24 may be accounted for by social and health disparities in BME populations being offset through the, relatively speaking, greater attention to medical treatment of physical health problems in patients in the care of mental health services.”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Health Consequences of Smoking: A Report of the Surgeon General
Office on Smoking (2004) · Cited by 2,414
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
Rao, J. N. K., & Scott, A. J. (1984) · The Annals of Statistics · doi:10.1214/aos/1176346391 · Cited by 1,286
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087
Schizophrenia and increased risks of cardiovascular disease
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070
The Lifetime Risk of Suicide in Schizophrenia: A Reexamination
Palmer, B. A., Pankratz, V. S., & Bostwick, J. M. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.3.247 · Cited by 1,026
Tobacco smoking and cancer: A meta‐analysis
Gandini, S., Botteri, E., Iodice, S., Boniol, M., Lowenfels, A. B., Maisonneuve, P., & Boyle, P. (2007) · International Journal of Cancer · doi:10.1002/ijc.23033 · Cited by 978
Botteri, E., Iodice, S., Bagnardi, V., Raimondi, S., Lowenfels, A. B., & Maisonneuve, P. (2008) · JAMA · doi:10.1001/jama.2008.839 · Cited by 824
Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., Lamberti, S., D'Agostino, R. B., Stroup, T. S., Davis, S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.010 · Cited by 528
Cited by
Sorted by citations
Items 101–158 of 158
Cybulski, Ł., Dewey, M. E., Hildersley, R., Morgan, C., Stewart, R. J., Wuerth, M., & Das‐Munshi, J. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae195 · Cited by 7
Zhang, X. Y., Rao, W., Yu, Q., Yu, Y., Kou, C., Tan, Y., Chen, D.-C., Zuo, L., Luo, X., & Soares, J. C. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32398 · Cited by 7
Caponnetto, P., & Polosa, R. (2020) · Health Psychology Research · doi:10.4081/hpr.2020.9237 · Cited by 7
Pinho, S., Rocha, V., & Vieira‐Coelho, M. A. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.03.012 · Cited by 9
Rapid Smoking May Not be Aversive in Schizophrenia
Williams, J. M., Gandhi, K. K., Lu, S., Steinberg, M. L., & Benowitz, N. L. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr314 · Cited by 7
Mak, Y. W., Chiang, C. L. V., & Loke, A. Y. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17010321 · Cited by 6
Smoking Behavior and the Use of Cigarette Types Among University Student
Arisona, A., Rahayuwati, L., Prawesti, A., & Agustina, H. S. (2020) · Journal of Educational and Social Research · doi:10.36941/jesr-2020-0100 · Cited by 6
Berry, A., Yung, A. R., Carr, M., Webb, R. T., Ashcroft, D. M., Firth, J., & Drake, R. (2020) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgaa069 · Cited by 7
Busch, A. M., Nederhoff, D. M., DUNSIGER, S. I., Japuntich, S. J., Chrastek, M., Adkins-Hempel, M., Rinehart, L., & Lando, H. A. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03113-5 · Cited by 5
Ahmed, S., Reena, R., Hussain, N., Ahmed, R., Amin, S., Ahmed, S. I., & Washdave (2015) · International Journal of Emergency Mental Health and Human Resilience · doi:10.4172/1522-4821.1000135 · Cited by 4
Berry, A., Drake, R., & Yung, A. R. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-05654-z · Cited by 7
Motivational Interviewing Produces Change Talk in Smokers with Serious Mental Illness
Billingsley, B., & Steinberg, M. L. (2021) · Journal of Dual Diagnosis · doi:10.1080/15504263.2021.1896826 · Cited by 5
Maladie cardiovasculaire et diabète chez les personnes atteintes d’une maladie mentale sévère
Scheen, A. J., Gillain, B., & Hert, M. D. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70021-3 · Cited by 6
Smoking and attention in schizophrenia spectrum disorders: What are we neglecting?
Keřková, B., Knížková, K., Siroňová, A., Hrubý, A., Večeřová, M., Šustová, P., Jonáš, J., & Rodríguez, M. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1114473 · Cited by 4
Medical Illnesses in People with Schizophrenia
El-Mallakh, P. L., Howard, P. B., & Evans, B. N. (2010) · Nursing Clinics of North America · doi:10.1016/j.cnur.2010.06.008 · Cited by 5
A pilot study of wellness coaching for smoking cessation among individuals with mental illnesses
Gao, N., Solomon, P., Clay, Z., & Swarbrick, P. (2021) · Journal of Mental Health · doi:10.1080/09638237.2021.1922630 · Cited by 4
Varenicline Should Be Used as a First-Line Treatment to Help Smokers With Mental Illness Quit
Williams, J. M. (2012) · Journal of Dual Diagnosis · doi:10.1080/15504263.2012.670848 · Cited by 4
Potvin, S., Tikàsz, A., Lungu, O., Stip, É., Zaharieva, V., Lalonde, P., Lipp, O., & Mendrek, A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00109 · Cited by 4
Kertes, J., Stein-Reisner, O., Grunhaus, L. J., & Neumark, Y. D. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1942057 · Cited by 4
Metabolic Challenges in Schizophrenia
Khan, M. (2013) · Journal of Psychology & Psychotherapy · doi:10.4172/2161-0487.1000115 · Cited by 3
Caponnetto, P., & Polosa, R. (2020) · Journal of Addictive Diseases · doi:10.1080/10550887.2020.1826097 · Cited by 3
Kallio, M., Korkeila, J. A., Malmberg, M., Gunn, J. M., Rautava, P. T., Korhonen, P. E., & Kytö, V. (2022) · BJPsych Open · doi:10.1192/bjo.2022.10 · Cited by 3
Szerman, N., Carlos, P., Pinet, C., Martínez-Raga, J., Basurte, I., & Sáiz, P. A. (2022) · Actas Españolas de Psiquiatría · Cited by 4
Pratt, S. I., Ferron, J. C., Santos, M. M., Brunette, M. F., Bianco, C. L., Sargent, J. D., & Xie, H. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112740 · Cited by 2
Deciphering the paradoxical incidence of cancer in schizophrenia
Kuppili, P. P., & Nebhinani, N. (2018) · Australasian Psychiatry · doi:10.1177/1039856218797439 · Cited by 2
López‐Cuadrado, T., Szmulewicz, A., Öngür, D., & Martínez‐Alés, G. (2023) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2023.08.004 · Cited by 2
Yu, T., Lee, T., Hsuan, C., Wu, C., Wang, C.-P., Lu, Y., Wei, C., Chung, F., Lee, Y., Tsai, I., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1309822 · Cited by 2
Leutwyler, H. C., Hubbard, E. M., Bussell, T., Balestra, D., Cooper, B. A., Souza, R. B., & Humfleet, G. L. (2024) · Games for Health Journal · doi:10.1089/g4h.2023.0160 · Cited by 2
Toward a Diathesis-Stress Model of Schizophrenia in a Neurodevelopmental Perspective
Berry, A., & Cirulli, F. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00013-4 · Cited by 2
Sociodemographic and Clinical Associations between Nicotine Dependence and Mental Illness
de Oliveira, R. M., Júnior, A., Santos, J. L. F., & Furegato, A. R. F. (2014) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2014/4894 · Cited by 2
Caponnetto, P., Idrisov, B. T., Signorelli, M. S., Krupitsky, E. M., Kiriazova, T. K., Nilforooshan, R., Cibella, F., Maglia, M. G., Saitta, D., Benfatto, F., et al. (2020) · medRxiv · doi:10.1101/2020.10.15.20141457 · Cited by 2
Donley, E. (2013) · Social Work in Mental Health · doi:10.1080/15332985.2013.832716 · Cited by 1
Smoking is associated with an increased risk of death in people aged 35–54 with schizophrenia
Tidey, J. W. (2011) · Evidence-Based Mental Health · doi:10.1136/ebmh.2011.100179 · Cited by 1
Schizophrenia Spectrum Disorders and Risk for Cancer Morbidity and Mortality
Ponizovsky, A. M., Weizman, A., & Grinshpoon, A. (2011) · Springer eBooks · doi:10.1007/978-94-007-0831-0_19 · Cited by 1
Pharmacotherapy for Smoking Cessation in Patients with Schizophrenia
Kim, S.-J., Jung, D.-U., & Kim, Y.-N. (2018) · Korean Journal of Schizophrenia Research · doi:10.16946/kjsr.2018.21.1.21 · Cited by 1
Medical Issues in Older Adults with Schizophrenia
Copeli, F., & Cohen, C. I. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108539593.008 · Cited by 1
Existing and emerging smoking cessation options for people with schizophrenia spectrum disorders
Caponnetto, P., DiPiazza, J., Signorelli, M. S., Maglia, M. G., & Polosa, R. (2018) · Journal of Addictive Diseases · doi:10.1080/10550887.2019.1679063 · Cited by 1
Moga, C. I., Micluția, I., & Crișan, C. A. (2023) · Medicina Moderna - Modern Medicine · doi:10.31689/rmm.2023.30.2.101 · Cited by 1
Maladie cardiovasculaire et diabète chez les personnes atteintes d’une maladie mentale sévère
Scheen, A. J., Gillain, B., & Hert, M. A. F. D. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70049-3 · Cited by 1
Kane, J. M., Fleischhacker, W., Kolitsopoulos, F. M., Karayal, O. N., Geier, J. L., SIU, C. O., Reynolds, R., Faich, G. A., & Strom, B. L. (2012) · Open Journal of Psychiatry · doi:10.4236/ojpsych.2012.224059
Souto, T. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/8naf-kf83
Tobacco harm reduction in people with serious mental illnesses
Squibb, B.-M., Richter, G., Personalized, V. E., Dj, K., & Frank, E. (2015)
Duncan, M. J. (2014) · TSpace (University of Toronto)
The Effects of Varenicline on Neurocognitive Function in Non-smokers with Schizophrenia
Kozak, K. (2016) · TSpace (University of Toronto)
Subramaniapillai, M. (2015) · TSpace (University of Toronto)
de Oliveira, R. M. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2017.tde-24012017-161236
Electronic cigarettes for smokers with schizophrenia spectrum disorders
Caponnetto, P. (2019) · Stirling Online Research Repository (University of Stirling)
Steinberg, M. L., Billingsley, B., Rosen, R., Epstein, E. E., Lu, S., Weickert, N., & Williams, J. M. (2020) · The Journal of Smoking Cessation · doi:10.1017/jsc.2020.19
(2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283514a53
Msosa, Y. J., Codling, D., Wang, T., Broadbent, M. T. M., Roberts, A., Harland, R., McGuire, P. K., Stewart, R. J., & Dobson, R. (2023) · Research Square · doi:10.21203/rs.3.rs-3161410/v1
Nicotine insensitivity and cue-controlled smoking behavior in people with schizophrenia
Hahn, B., & Holzel, E. S. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.10.034
Management of cardiovascular disease in patients with schizophrenia
Baek, J. H. (2024) · Journal of Korean Medical Association · doi:10.5124/jkma.2024.67.2.115
Malignant comorbidity: schizophrenia and smoking
Sivolap, Y. P., & Portnova, A. A. (2025) · Neurology Bulletin · doi:10.17816/nb643639
Grabowski, J., Bidzan, L., & Brzozowska, A. (2025) · Pharmaceuticals · doi:10.3390/ph18091366
Health Characteristics of Emerging and Young Adults with SMI
Brunette, M. F., Bourassa, J. G., Wallin, D. J., Ferron, J. C., Williams, G. E., Santos, M. M., & Pratt, S. I. (2026) · Community Mental Health Journal · doi:10.1007/s10597-026-01627-4
Antipsychotics and Their Association With Long‐Term Outcomes in Young Ischemic Stroke Patients
Broman, J., Aarnio, K., Granroth‐Wilding, H. M. V., Marinković, I., Kaste, M., Tatlisumak, T., & Jukka Putaala, A. (2026) · European Journal of Neurology · doi:10.1111/ene.70601
Salience attribution in addiction and psychosis
Freeman, T. P. (2013) · UCL Discovery (University College London)
Metadata
- Authors
- Kelly, D. L., McMahon, R. P., Wehring, H. J., Liu, F., Mackowick, K. M., Boggs, D. L., Warren, K. R., Feldman, S., Shim, J.-C., Love, R. C., & Dixon, L.
- Affiliations
- University of Maryland, Baltimore (US)
- Inje University (KR)
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-12-17
- Volume
- 37
- Issue
- 4
- Pages
- 832-838
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- PMC
- PMC3122289
- OpenAlex
- W2140909692
- Cited by
- 158
- References
- 39
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 3 · 2021: 7 · 2020: 9 · 2019: 8 · 2018: 6 · 2017: 16 · 2016: 11 · 2015: 16 · 2014: 11 · 2013: 21 · 2012: 17
- FWCI
- 7.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Schizophrenia Bulletin (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p50mh040279-05)
- National Institute of Mental Health (R03MH076985, P50 MH 40279)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Keywords
- cigarette smoking, mortality risk
- MeSH terms
- Adult, Age Factors, Aged, Cause of Death, Coronary Disease, Female, Humans, Male, Maryland, Middle Aged, Regression Analysis, Risk, Schizophrenia, Smoking, Antipsychotic Agents, Comorbidity, Proportional Hazards Models, Odds Ratio, Substance-Related Disorders, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
